Per- and polyfluoroalkyl substance plasma concentrations and metabolomic markers of type 2 diabetes in the Diabetes Prevention Program trial.
Mitro SD, Liu J, Jaacks LM, Fleisch AF, Williams PL, Knowler WC, Laferr?re B, Perng W, Bray GA, Wallia A, Hivert MF, Oken E, James-Todd TM, Temprosa M. Per- and polyfluoroalkyl substance plasma concentrations and metabolomic markers of type 2 diabetes in the Diabetes Prevention Program trial. Int J Hyg Environ Health. 2021 03; 232:113680.